Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 4Phase 1/2 1

Status

Completed 9Terminated 4Recruiting 4Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Sarcoma 1Plasma cell 1Myeloid 1

Conditions

Glioblastoma 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Oligodendroglioma 1Multiple Myeloma 1Gliosarcoma 1Glioma 1Astrocytoma 1

Interventions

Cyclophosphamide 98pembrolizumab 87Gemcitabine 81Carboplatin 63fludarabine 62Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 50Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 34Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26atezolizumab 25Pemetrexed 25Oxaliplatin 24Capecitabine 24fludarabine phosphate 23Filgrastim 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Ascorbic Acid × Clear all
NCT02168270 2023-11-24

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

University of Nebraska

Phase 1 Terminated
4 enrolled 6 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Oligodendroglioma, Gliosarcoma

NCT02833701 2023-10-24

Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma

University of Nebraska

Phase 1 Terminated
9 enrolled
CNS

Glioblastoma, Glioma

NCT01014546 2022-07-22

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

Roswell Park Cancer Institute

Phase 1 Terminated
5 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT00590603 2014-01-08

AAV

Duke University

Phase 1 Terminated
25 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡